pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
the cabinet

Drugs

6,918 products tracked · 1,486 matching

★ save view↓export CSV
phase
allMarketedPhase 3Phase 2Phase 1Preclinical
sort
catalystsrecentname
therapeutic area
allOncology1831Infectious Disease718Cardiology425Pulmonology396Immunology371Ophthalmology368Dermatology300Women's Health
viewlistcards
  • Phase 2
    lithium citrate
    Lithium Citrate
    Alzheimer's Disease Medesis Pharma SA
  • Phase 2
    litoxetine
    litoxetine [INN]
    Stress Urinary Incontinence Vaneltix Pharma Inc
  • Phase 2
    lixadesiran + pixofisiran
    lixadesiran [INN] + pixofisiran [INN]
    Basal Cell Carcinoma (Basal Cell Epithelioma) Sirnaomics Ltd
  • Phase 2
← prev
page 40 of 50
next →
131
Pain89
Neurology1
lixosicone
lixosicone [INN]
Substance (Drug) Abuse
Aelis Farma SAS
  • Phase 2
    lonigutamab
    lonigutamab [INN]
    Graves' Ophthalmopathy$ALMS ALUMIS INC.
  • Phase 2
    lorigerlimab
    lorigerlimab
    Colorectal Cancer$MGNX MACROGENICS INC
  • Phase 2
    lucicebtide
    lucicebtide
    Esophageal Cancer Sapience Therapeutics Inc
  • Phase 2
    lucinactant
    lucinactant
    Coronavirus Disease 2019 (COVID-19) Associated Acute Resp… Lee's Pharmaceutical Holdings Ltd
  • Phase 2
    ludotadipep
    Metastatic Castration-Resistant Prostate Cancer (mCRPC) FutureChem Co Ltd
  • Phase 2
    lufepirsen
    Nexagon (lufepirsen [INN])
    Persistent Corneal Epithelial Defects Amber Ophthalmics Inc
  • Phase 2
    lumacaftor
    lumacaftor
    Subarachnoid Hemorrhage Qanatpharma AG
  • Phase 2
    lunbotinib
    lunbotinib [INN]
    Non-Small Cell Lung Cancer Ellipses Pharma Ltd
  • Phase 2
    luvesilocin
    luvesilocin [INN]
    Post Partum Depression (Maternal Depression / Postnatal D… Reunion Neuroscience Inc
  • Phase 2
    luvixasertib
    luvixasertib [INN]
    Human Epidermal Growth Factor Receptor 2 Negative Breast… Treadwell Therapeutics Inc
  • Phase 2
    luvomeran
    luvomeran
    Cystic Fibrosis$VERX Vertex, Inc.
  • Phase 2
    luvometinib
    luvometinib [INN]
    Neurofibromatoses Type I (Von Recklinghausen's Disease) Shanghai Fosun Pharmaceutical (Group) Co Ltd
  • Phase 2
    mRNA-3705
    Methylmalonic Acidemia$MRNA Moderna, Inc.
  • Phase 2
    mRNA-3927
    Propionic Acidemia$MRNA Moderna, Inc.
  • Phase 2
    mRNA-4359
    Solid Tumor$MRNA Moderna, Inc.
  • Phase 2
    malaria [strain NF-54] vaccine 2
    Malaria Sanaria Inc
  • Phase 2
    margetuximab
    Margenza (margetuximab-cmkb)
    Gastric Cancer TerSera Therapeutics LLC
  • Phase 2
    maveropepimut-s
    maveropepimut-s
    Fallopian Tube Cancer$BVAXF BioVaxys Technology Corp.
  • Phase 2
    mavrilimumab
    mavrilimumab
    Rheumatoid Arthritis MedImmune Ltd
  • Phase 2
    mavrostobart
    mavrostobart
    Solid Tumor Phanes Therapeutics Inc
  • Phase 2
    mazindol ER
    Quilience (mazindol)
    Idiopathic Hypersomnia (IH)$NCEL NewcelX Ltd.
  • Phase 2
    mebufotenin
    mebufotenin [INN]
    Treatment Resistant Depression$ATAI AtaiBeckley Inc.
  • Phase 2
    mecasermin rinfabate
    mecasermin rinfabate
    Bronchopulmonary Dysplasia Chiesi Farmaceutici SpA
  • Phase 2
    mecbotamab vedotin
    mecbotamab vedotin
    Non-Small Cell Lung Cancer$BCAB BioAtla, Inc.
  • Phase 2
    meningococcal (pentavalent) vaccine
    MenPenta
    Neisseria meningitidis Infections$SNY Sanofi
  • Phase 2
    meplazumab
    Ketantin
    Malaria Jiangsu Pacific Meinuoke Bio-Pharmarceutical Co Ltd